Literature DB >> 19869539

STUDIES ON FOWL PARALYSIS (NEUROLYMPHOMATOSIS GALLINARUM) : II. TRANSMISSION EXPERIMENTS.

A M Pappenheimer1, L C Dunn, S M Seidlin.   

Abstract

1. Inoculation of suspensions of brain, cord, ganglia or nerves of chickens with neurolymphomatous lesions, into newly hatched chicks, is followed by the development of typical lesions in approximately 25 per cent of cases. 2. In control chickens kept under laboratory conditions the incidence of the disease is about 7 per cent. 3. The disease does not become manifest until at least 2 months after inoculation; symptoms may not appear until after 4 months. 4. The active agent is not destroyed by 50 per cent glycerol in 9 days at ice box temperature.

Entities:  

Year:  1929        PMID: 19869539      PMCID: PMC2131515          DOI: 10.1084/jem.49.1.87

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  Characterization of the gene encoding herpesvirus of turkeys gp57-65: comparison to Marek's disease virus gp57-65 and herpes simplex virus glycoprotein C.

Authors:  P M Coussens; M R Wilson; H Camp; H Roehl; R J Isfort; L F Velicer
Journal:  Virus Genes       Date:  1990-04       Impact factor: 2.332

Review 2.  Advances on Innate Immune Evasion by Avian Immunosuppressive Viruses.

Authors:  Hongnuan Wang; Wei Li; Shijun J Zheng
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

3.  A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis.

Authors:  Sascha Trapp; Mark S Parcells; Jeremy P Kamil; Daniel Schumacher; B Karsten Tischer; Pankaj M Kumar; Venugopal K Nair; Nikolaus Osterrieder
Journal:  J Exp Med       Date:  2006-05-01       Impact factor: 14.307

4.  Diffuse large B-cell lymphoma presenting with neurolymphomatosis and intravascular lymphoma: a unique autopsy case with diverse neurological symptoms.

Authors:  Sohsuke Yamada; Akihide Tanimoto; Atsunori Nabeshima; Takashi Tasaki; Ke-Yong Wang; Shohei Kitada; Hirotsugu Noguchi; Yasuyuki Sasaguri
Journal:  Diagn Pathol       Date:  2012-08-13       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.